Showing results 3 to 8 of 8
< previous
| Title | Author(s) | Issue Date | Views | |
|---|---|---|---|---|
RO7062931 antisense oligonucleotide phase 1 study demonstrates target engagement in patients with chronic hepatitis B on established nucleos(t)ide therapy Proceeding/Conference:Journal of Hepatology | 2020 | 49 | ||
| 2019 | 35 | |||
| 2021 | ||||
The pharmacokinetic and safety profiles of RO7445482 SIRNA are similar between Asian and nonAsian healthy volunteers and chronic hepatitis B patients in a phase 1 Study Proceeding/Conference:Poster presentation at the AASLD The Liver Meeting, November 12-15. 2021. Hepatology | 2021 | |||
TLR7 agonist ro7020531 triggers immune activation after multiple doses in chronic hepatitis B patients Proceeding/Conference:Hepatology | 2018 | 108 | ||
Viral nucleic acids suppression activity of RO7049389 plus NUC with/without Peg-IFN in virologically-suppressed and naive chronic hepatitis B patients: 48-week treatment and posttreatment follow-up. Poster Presentation (SAT427) Proceeding/Conference:The International Liver Congress 2022, 22-26 June 2022. Journal of Hepatology | 2022 |